Lawitz, E. J., Dvory-Sobol, H., Doehle, B. P., Worth, A. S., McNally, J., Brainard, D. M., . . . Mo, H. (2016). Clinical Resistance to Velpatasvir (GS-5816), a Novel Pan-Genotypic Inhibitor of the Hepatitis C Virus NS5A Protein. Antimicrob Agents Chemother.

Lawitz, Eric J., Hadas Dvory-Sobol, Brian P. Doehle, Angela S. Worth, John McNally, Diana M. Brainard, John O. Link, Michael D. Miller, and Hongmei Mo. "Clinical Resistance to Velpatasvir (GS-5816), a Novel Pan-Genotypic Inhibitor of the Hepatitis C Virus NS5A Protein." Antimicrob Agents Chemother 2016.

Lawitz, Eric J., et al. "Clinical Resistance to Velpatasvir (GS-5816), a Novel Pan-Genotypic Inhibitor of the Hepatitis C Virus NS5A Protein." Antimicrob Agents Chemother 2016.